Zanjan University of Medical Sciences English Web · About ZUMS · News · Contact us · Site Map · RSS 2.0 · Library · فارسي
Main Menu
What is Gene Therapy::
Administrative Offices::
Policy Council::
Research Committee::
Papers::
Useful Links::
Contact us::
::
Search in website

Advanced Search
..
..
..
..
:: Gene Therapy Application ::
 | Post date: 2019/10/8 | 
Gene Therapy Applications
Gene targeting through ZFNs or TALEN-based approaches can also be used to modify defective genes at their endogenous chromosomal locations. Examples include the treatment of X-linked severe combined immunodeficiency (X-SCID) by ex vivo gene correction with DNA carrying the interleukin-2 receptor common gamma chain (IL-2Rγ) and the correction of Xeroderma pigmentosum mutations in vitro using TALEN. Insertional mutagenesis by the retroviral vector genome induced leukemia in some patients, a problem that is predicted to be avoided by these technologies. However, ZFNs may also cause off-target mutations, in a different way from viral transductions. Currently, many measures are taken to improve off-target detection and ensure safety before treatment.
View: 427 Time(s)   |   Print: 42 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)
Click here to see all texts in Gene Therapy Application topic.
مرکز تحقیقات ژن درمانی سرطان Cancer Gene Therapy Research Center (CGRC)